Overview

Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy

Status:
Unknown status

Trial end date:
2019-10-31

Target enrollment:

Participant gender:

Summary

Correction of the deficit in the perfusion pressure of the microcirculation that supplies the nerve by intravenous infusion of Prostaglandin E1 (PGE1) (Alprostadil), expected to improve visual function in patients with ischemic optic neuropathy previous non-arteritic (NOIANA).

Phase:

Phase 2

Details

Lead Sponsor:

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Treatments:

Alprostadil